Read this first. Biotech Stock Reports publishes opinion and educational content about high-risk, speculative securities. It is not investment advice, and it is not independent of the companies it may do business with. The publication is operated by DEALITHIC, an investor-relations firm. Never make an investment decision based on this site alone.
1Not investment advice
Biotech Stock Reports is a financial-media publication operated by DEALITHIC. All content — including watch lists, company profiles, and analysis — is provided for general informational and educational purposes only and reflects the opinions of its authors as of the date of publication. Nothing on this site is, or should be construed as, investment, financial, legal, tax, or accounting advice, a research report, or a recommendation, endorsement, offer, or solicitation to buy, sell, or hold any security. We are not a registered investment adviser, broker-dealer, or financial planner, and no content here is tailored to your individual circumstances or creates any advisory or fiduciary relationship.
2High-risk, speculative securities
The companies we cover are predominantly early-stage, clinical- or preclinical-stage biotechnology companies, and many are small-cap or micro-cap securities. Investing in them involves a high degree of risk — including clinical-trial failure, regulatory rejection or delay, manufacturing risk, and the need for additional financing that may substantially dilute existing shareholders — and can result in the loss of your entire investment. Small- and micro-cap shares may be illiquid and highly volatile. Preclinical or clinical results described on this site do not predict future outcomes, and no drug candidate we discuss should be assumed to be approved for any indication unless expressly stated.
3Do your own research
You are solely responsible for your own investment decisions. Always conduct your own due diligence, verify all information against each company's official filings (with the SEC, SEDAR+, or the relevant regulator) and press releases, and consult a licensed financial professional before making any investment decision.
4Forward-looking statements
Our content references forward-looking information — including anticipated trial timelines, IND submissions, regulatory decision dates (such as advisory-committee and PDUFA dates), and other catalysts — that is inherently uncertain and subject to change. Such dates and events may be delayed, altered, or cancelled, and actual results may differ materially from any expectation expressed or implied on this site.
5Accuracy & market data
Share prices, market capitalizations, share counts, and 52-week ranges are approximate and shown as of the dates indicated; these figures change continuously and should be re-verified against a live source before you rely on them. Company facts are drawn from public disclosures believed to be reliable but are not warranted to be complete, current, or error-free. We may update or correct content at any time without notice.
6Affiliation & compensation
Biotech Stock Reports is owned and operated by DEALITHIC, a financial-technology and investor-relations firm. DEALITHIC provides investor-relations, marketing, and related services to public and private companies. As a result, Biotech Stock Reports is not independent of the companies it may cover: we may have existing business relationships with, or may actively seek to establish business relationships with, companies featured on this site, including companies profiled favorably.
Where Biotech Stock Reports (or DEALITHIC) has been compensated by, or has a material business relationship with, a company featured on this site, that relationship will be clearly and specifically disclosed on the relevant page. In addition, the publisher, DEALITHIC, their respective principals, employees, and affiliates may hold, acquire, or dispose of positions in the securities mentioned at any time, without notice. You should assume that a conflict of interest may exist and weigh our content accordingly.
7No warranties
This site and its content are provided "as is" and "as available," without warranties of any kind, express or implied, including as to accuracy, completeness, merchantability, or fitness for a particular purpose. To the fullest extent permitted by law, Biotech Stock Reports, DEALITHIC, and their principals, employees, and affiliates disclaim all liability for any loss or damage of any kind arising from your use of, or reliance on, any content on this site.
8Third-party links
This site contains links to third-party websites, including the investor-relations pages of companies we cover. Those sites are not under our control, and we are not responsible for their content, accuracy, or practices. A link does not constitute an endorsement.
9Contact
Questions about this disclaimer, or corrections to our content, can be sent via the contact form on our About page. See also About Biotech Stock Reports.